Onco Actu du 3 janvier 2017

	3.1 Tabac
Mary E Black: New Year’s resolution—a smoke-free NHS [BMJ Blogs] The NHS is not yet smoke free. But it’s time that it was. If this had happened years ago then perhaps I would not be able to darn so well. Perhaps my father would still be alive.
	4.2 Dép., diag. & prono. - Génome
China’s $9 billion effort to beat the U.S. in genetic testing [Washington Post] Scientist and entrepreneur Ge Li is a poster child for China’s new model. Trained at Columbia University, Li was working as a laboratory scientist in Philadelphia in 2000 when he realized he could replicate his job in his home country for a fraction of the cost. His company, WuXi AppTec, which includes WuXi NextCODE, is now estimated to be worth more than $3.3 billion.
	5. Traitements
Life-extending capacity of new cancer drugs varies widely [Reuters] Researchers looked at the 62 cancer drugs approved in the U.S. and Europe between 2003 and 2013 and found they extended survival by an average of about 3.5 months.
	5.10 Traitements - Essais
Are scientific advances getting harder to achieve? If so, what do we do? [The Incidental Economist] Bloom et al. produce data indicating that the number of lives saved per cancer research publication or per clinical trial is declining, a nearly 8-fold decline over 30 years in the lives saved / 100,000 population per cancer clinical trial.
	6.6 Publications
2016: The Year in Review [ORCID] This year’s 50% increase in new ORCID iDs has brought us to a total of 2.9 million active iDs that can be used in over 500 systems worldwide.
	6.7 DMP, Big Data & applis
The Health Data Conundrum [NY Times] Yes, giving consumers control of their own medical data would revolutionize who owns medical data and how it is used. Concerns about researchers losing access to this amassed data are overstated.